Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1984;63:155-162
© 1984 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HACKER, N. F.
Right arrow Articles by LEUCHTER, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HACKER, N. F.
Right arrow Articles by LEUCHTER, R. S.

Individualization of Treatment for Stage I Squamous Cell Vulvar Carcinoma

NEVILLE F. HACKER, MD, JONATHAN S. BEREK, MD, LEO D. LAGASSE, MD, ROBERTA K. NIEBERG, MD and RONALD S. LEUCHTER, MD

From the Division of Gynecologic Oncology and the Department of Pathology, UCLA School of Medicine; and The Jonsson Comprehensive Cancer Center, Los Angeles, California

Abstract

Of 177 cases of invasive squamous cell vulvar cancer seen at the University of California at Los Angeles and the City of Hope National Medical Center from 1957 to 1980, 84 (47.5%) had stage I disease. Seventy-seven patients with stage I disease (91.7%) had stromal invasion of 5 mm or less. Correlation between lymph node status and depth of invasion was as follows: 1 mm or less, none of 34 (0%); 1.1 to 2 mm, two of 19 (10.5%); 2.1 to 3 mm, two of 17 (11.8%); 3 to 5 mm, one of seven (14.3%); more than 5 mm, three of seven (42.9%). Fifty-six patients had radical vulvectomy for the primary lesion, and 28 had more conservative excision, but the incidence of local invasive recurrence (4%) was the same in each group. None of 58 patients treated with inguinalfemoral lymphadenectomy developed a groin recurrence, but three of 26 patients (11.5%) who had omission or modification of inguinal-femoral lymphadenectomy died with groin recurrence within 12 months. These data suggest that although some modification of the standard radical vulvectomy is appropriate for the primary lesion in patients with stage I disease, patients with greater than 1 mm of stromal invasion require at least an ipsilateral inguinalfemoral lymphadenectomy.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
F. B. Stehman and K. Y. Look
Carcinoma of the vulva.
Obstet. Gynecol., March 1, 2006; 107(3): 719 - 733.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
H C Kitchener
Progress in the management of solid tumours: Gynaecological cancer
Postgrad. Med. J., June 1, 1999; 75(884): 332 - 338.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American College of Obstetricians and Gynecologists.